Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Formoterol and budesonide inhalation sequence study in mild asthma
2005-002462-11Phase 4Completed
- Sponsor
- Pulmonary Research Institute GmbH an der Asklepiosklinik Barmbek. Niederlassung Hamburg.
- Start
- Aug 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of formoterol and budesonide in asthma (2 arms), sponsored by Pulmonary Research Institute GmbH an der Asklepiosklinik Barmbek. Niederlassung Hamburg. Primary endpoints: Primary efficacy endpoint and Fractional exhaled nitric oxide. Started Aug 2005; status: completed.
02
Drugs
formoterolbudesonide
03
Conditions
asthma
Beyond the preview
Go deeper on 2005-002462-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002462-11.